QIAGEN N.V. QGEN
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.10B | 2.10B | 2.09B | 2.07B | 2.04B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.10B | 2.10B | 2.09B | 2.07B | 2.04B |
| Cost of Revenue | 712.50M | 716.48M | 708.94M | 414.33M | 406.36M |
| Gross Profit | 1.39B | 1.38B | 1.38B | 1.66B | 1.63B |
| SG&A Expenses | 586.14M | 588.12M | 583.67M | 571.51M | 569.06M |
| Depreciation & Amortization | 63.45M | 63.55M | 63.24M | 61.37M | 61.81M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.56B | 1.56B | 1.54B | 1.24B | 1.22B |
| Operating Income | 543.60M | 538.73M | 546.64M | 834.69M | 818.25M |
| Income Before Tax | 461.83M | 456.55M | 490.27M | 506.95M | 488.68M |
| Income Tax Expenses | 52.51M | 54.38M | 65.39M | 101.58M | 115.29M |
| Earnings from Continuing Operations | 409.32 | 402.17 | 424.88 | 405.37 | 373.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 409.32M | 402.17M | 424.88M | 405.37M | 373.39M |
| EBIT | 543.60M | 538.73M | 546.64M | 834.69M | 818.25M |
| EBITDA | 727.73M | 721.78M | 722.38M | 1.01B | 994.18M |
| EPS Basic | 1.98 | 1.95 | 2.06 | 1.96 | 1.81 |
| Normalized Basic EPS | 1.69 | 1.69 | 1.73 | 2.60 | 2.55 |
| EPS Diluted | 1.98 | 1.94 | 2.04 | 1.95 | 1.79 |
| Normalized Diluted EPS | 1.68 | 1.69 | 1.72 | 2.59 | 2.54 |
| Average Basic Shares Outstanding | 827.14M | 826.66M | 827.11M | 826.47M | 825.77M |
| Average Diluted Shares Outstanding | 832.06M | 831.50M | 831.75M | 831.10M | 830.49M |
| Dividend Per Share | 0.35 | 0.35 | 0.26 | 0.26 | 0.26 |
| Payout Ratio | 13.25% | 13.49% | 12.77% | 13.38% | -- |